Spectinomycin
Spectinomycin, sold under the tradename Trobicin among others, is an antibiotic useful for the treatment of gonorrhea infections. It is given by injection into a muscle.
Clinical data | |
---|---|
Trade names | Trobicin |
Other names | (2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)decahydro-4H-pyrano[2,3-b][1,4]benzodioxin-4-one , SPT/SPE/SC/SP |
AHFS/Drugs.com | Monograph |
Routes of administration | IM |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.015.374 |
Chemical and physical data | |
Formula | C14H24N2O7 |
Molar mass | 332.353 g·mol−1 |
3D model (JSmol) | |
Melting point | 184 to 194 °C (363 to 381 °F) |
| |
| |
(what is this?) (verify) |
Common side effects include pain at the area of injection, rash, nausea, fever, and trouble sleeping. Severe allergic reactions may occasionally occur. It is generally safe to use during pregnancy. It may be used by those who are allergic to penicillin or cephalosporins. It is in the aminocyclitol class of drugs and works by stopping the making of protein by certain bacteria.
Spectinomycin was discovered in 1961. It is on the World Health Organization's List of Essential Medicines. It is not available in the United States for human use. It is made from the bacterium Streptomyces spectabilis.